webinars.endpts.com Open in urlscan Pro
54.185.102.17  Public Scan

Submitted URL: https://e.endpointsnews.com/t/t-l-zirujjy-jrjtluirld-yh/
Effective URL: https://webinars.endpts.com/maximizing-efficiency-in-your-next-state-of-the-art-facility-build/?source=pharma
Submission: On June 28 via api from US — Scanned from DE

Form analysis 0 forms found in the DOM

Text Content

 * Endpoints News
 * register now

June 29
11:00 am - 12:00 pm EDT
15:00 - 16:00
LOCAL TIME


MAXIMIZING EFFICIENCY IN YOUR NEXT STATE-OF-THE-ART FACILITY BUILD

In this panel discussion moderated by Project Farma, experts from Spark,
Cellares and Baseline Controls will explore:

 * Implementing effective program/project management and communication tools to
   drive adherence to cost, schedule and quality
 * Establishing robust project controls and integrated schedules early and
   maintaining discipline throughout the build
 * Developing risk-based approaches for various phases including design,
   construction, CQV and quality
 * Effective strategies to minimize risk of supply chain delays
 * Integrating operational readiness early to ensure timely facility startup

SPONSORED BY

SHARE ON

0

days

17

hours

56

minutes
register now
register for the webinar
First name
Last name
Email
Company
Job Title
Country --select--AfghanistanÅland IslandsAlbaniaAlgeriaAmerican
SamoaAndorraAngolaAnguillaAntarcticaAntigua and
BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire,
Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish
Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo
VerdeCambodiaCameroonCanadaCayman IslandsCentral African
RepublicChadChileChinaChristmas IslandCocos (Keeling)
IslandsColombiaComorosCongoCongoCook IslandsCosta RicaCôte
d'IvoireCroatiaCuraçaoCyprusCzechiaDenmarkDjiboutiDominicaDominican
RepublicEcuadorEgyptEl SalvadorEquatorial
GuineaEritreaEstoniaEswatiniEthiopiaFalkland Islands (Malvinas)Faroe
IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern
TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard
Island and McDonald IslandsHoly SeeHondurasHong Kong
SARHungaryIcelandIndiaIndonesiaIraqIrelandIsle of
ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKoreaKuwaitKyrgyzstanLao
People's Democratic
RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacau
SARMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall
IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew
CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorthern Mariana
IslandsNorth MacedoniaNorwayOmanPakistanPalauPalestinePanamaPapua New
GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto
RicoQatarRéunionRomaniaRussian FederationRwandaSaint BarthélemySaint Helena,
Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint Martin
(French part)Saint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan
MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra
LeoneSingaporeSint Maarten (Dutch part)SlovakiaSloveniaSolomon
IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth
SudanSpainSri LankaSurinameSvalbard and Jan
MayenSwedenSwitzerlandTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad
and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos
IslandsTuvaluUgandaUkraineUnited Arab EmiratesUnited KingdomUnited States Minor
Outlying IslandsUnited States of AmericaUruguayUzbekistanVanuatuVenezuelaViet
NamVirgin Islands (British)Virgin Islands (U.S.)Wallis and FutunaWestern
SaharaYemenZambiaZimbabweOther
register

No cost to register, subject to confirmation

By registering for this event, you accept that you may receive direct
communication from the sponsor(s).

If you are experiencing problems with your registration, please try the Zoom
registration page.


ADAM BARLOW

CEO AND FOUNDER, BASELINE CONTROLS

Adam Barlow is principal and founder of Baseline Controls Inc. He founded
Baseline Controls Inc. in 2010 and currently leads a team of project support
professionals. Baseline Controls Inc. specializes in providing its
project-centric clients with project management consulting services including
strategic and tactical planning, project control services, program management
and project execution support. Baseline Controls Inc. professionals seamlessly
integrate with clients and use a cost-effective planning approach to deliver
programs and projects on time and under budget.


ANTINEA CHAIR

VP, TECHNICAL OPERATIONS, CELLARES

Antinea is the Vice President of Technical Operations at Cellares. She brings
over a decade of experience in the Life Sciences industry, having held senior
leadership responsibilities in Cell Manufacturing, Technical Operations, MSAT,
Supply Chain, Engineering, and Program Management.

Prior to joining Cellares, Antinea oversaw the design, build, and deployment of
Synthego's High-Throughput Genome Engineering Technology, a cell-line agnostic
platform accelerating researchers' CRISPR-mediated target identification and
validation initiatives. She led the commercial launch of CRISPR-edited iPSCs and
Engineered Cell Libraries to upend mainstream therapeutic development
approaches, enabling researchers to gain valuable diversity, toxicity, and
efficacy insights in-situ, de-risking costly therapeutic endeavors far ahead of
traditional patient trials. In partnership with the NIH, she led the generation
of isogenic-induced pluripotent stem cell (iPSC) lines to establish a national
repository to characterize how individual mutations impact cellular pathways and
contribute to Alzheimer’s and other neurological indications.

At Novartis, Antinea drove readiness and successful completion of FDA
pre-approval inspections (PAI). Antinea holds a Bachelor of Science in Microbial
Biology from the University of California, Berkeley and has made it her mission
to understand, optimize, and accelerate access to curative therapeutic
modalities reinforced through years of innovative, customer-centric genomic
advancements across all stages of the drug development process.


STEVE MARR

HEAD OF CAPITAL, REAL ESTATE, AND FACILITIES, SPARK

Steve is a global biopharmaceutical executive with extensive experience leading
large organizations with up to 4,000 personnel in the biopharmaceutical and
nuclear industries. Steve spent 26 years in the United States Navy as a nuclear
submarine officer where he held several key leadership positions including
Commanding Officer of the USS SALT LAKE CITY (SSN 716) as well as Commodore of
Submarine Squadron ONE in Pearl Harbor, Hawaii. Steve retired from the Navy as a
Captain in 2009.

After retiring from the Navy, Steve spent four years in the civilian nuclear
industry working for Areva and then Westinghouse as a project director for large
multi-billion dollar new nuclear facilities. In 2014, Steve transitioned to the
pharmaceutical industry. He first joined Shire Pharmaceuticals as a project
director and site lead where he successfully delivered a new $2B manufacturing
facility. Steve spent 3 years as the Head of Capital Programs for Shire where he
was accountable for developing and implementing capital management programs and
services with direct oversight of the $1B annual capital budget. Steve joined
the Spark team in April 2020 as the Head of Real Estate, Corporate Facilities
and Capital Programs where he is responsible for leading the evolution of
Spark’s expanding corporate facilities portfolio and long term facilities
strategy.

Steve is originally from Longmeadow, Massachusetts. He received a B.S. in Ocean
Engineering from the United States Naval Academy. He currently resides in
Philadelphia, Pennsylvania with his wife, Robin. They have 3 grown children.


MATTHEW SMITH

HEAD OF PROJECT DELIVERY (INDIANAPOLIS), NOVARTIS


SARAH STOLL

SENIOR DIRECTOR II, PROJECT FARMA

Sarah Stoll is a Senior Director II at Project Farma. She has 10+ years of
experience in capital projects in the pharmaceuticals, biotechnology, and
advanced medicines industry. Sarah has held multiple project lead roles with the
most recent being lead on a 500+ million state-of-the-art greenfield facility
for complex biologics. She has led diverse, cross-functional teams throughout
the entire project lifecycle including project initiation/funding requests,
business case development, conceptual design, basis of design, detailed design,
construction, commissioning, qualification and validation, and facility startup.

MODERATOR


CHAD SALISBURY

SENIOR VICE PRESIDENT, PROJECT FARMA

Chad Salisbury joined Project Farma in October 2022 as Senior Vice President.
Chad has over 20 years of experience encompassing gene therapy, vaccines,
sterile injectables and small molecules, including the delivery of ~$2B USD of
greenfield cGMP manufacturing facilities. Chad has held increasingly responsible
management positions in manufacturing, quality, engineering and supply chain.

Chad was most recently VP, Manufacturing at Affinia Therapeutics, a company
singularly focused on using innovations in gene therapy to lead the fight
against devastating rare and prevalent diseases. Prior to Affinia, Chad held
progressive roles at CSL Seqirus, Novartis and Eli Lilly in both the US and
Europe.

Chad holds an MBA from Purdue University, an MEM from Duke University and a B.A.
from Alfred University.

close


YOUR SEAT IS RESERVED!


MAXIMIZING EFFICIENCY IN YOUR NEXT STATE-OF-THE-ART FACILITY BUILD

11:00 am - 12:00 pm EDT
15:00 - 16:00 LOCAL TIME

A confirmation email with information on how to join the webinar has been sent
to you.

Before joining, be sure to check system requirements to avoid any connection
issues.

close


REGISTRATION DECLINED


MAXIMIZING EFFICIENCY IN YOUR NEXT STATE-OF-THE-ART FACILITY BUILD

Apologies, the sponsor for this webinar has opted to block certain domains.

Please feel free to check out our other upcoming webinars at
https://webinars.endpts.com/